Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)

INTRODUCTION: Pegylated granulocyte colony-stimulating factor (G-CSF) has been widely used for preventing febrile neutropenia in various types of cancer treatment. In the present study, we prospectively evaluated the safety and efficacy of pegfilgrastim as a primary prophylaxis of febrile neutropeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Ga-Young, Lee, Je-Jung, Moon, Joon Ho, Kim, Dajung, Kim, Min Kyoung, Kim, Hyo Jung, Mun, Yeung-Chul, Lee, Won-Sik, Do, Young Rok, Lee, Jae Hoon, Jung, Sung-Hoon, Kim, Jin Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642200/
https://www.ncbi.nlm.nih.gov/pubmed/37965454
http://dx.doi.org/10.3389/fonc.2023.1209110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642200/
https://www.ncbi.nlm.nih.gov/pubmed/37965454
http://dx.doi.org/10.3389/fonc.2023.1209110

Ejemplares similares